References
- Matuszkiewicz-Rowinska J. Update on fungal peritonitis and its treatment. Perit Dial Int. 2009;29(Suppl. 2):S161–S165
- Bonfante L, Nalesso F, Cara M, et al. Aspergillus fumigatus peritonitis in ambulatory peritoneal dialysis: a case report and notes on the therapeutic approach. Nephrology. 2005;10:270–273
- Schattner A, Kagan A, Zimhony O. Aspergillus peritonitis in a lupus patient on chronic peritoneal dialysis. Rheumatol Int. 2006;26:762–764
- Raaijmakers R, Schroder C, Monnens L, Cornelissen E, Warris A. Fungal peritonitis in children on peritoneal dialysis. Pediatr Nephrol. 2007;22:288–293
- Bibashi E, Papagianni A, Kelesidis A, Antoniadou R, Papadimitriou M. Peritonitis due to Aspergillus niger in a patient on continuous ambulatory peritoneal dialysis shortly after kidney graft rejection. Nephrol Dial Transplant. 1993;8:185–187
- Speth C, Rambach G, Wurzner R, Lass-Florl C. Complement and fungal pathogens: an update. Mycoses. 2008;51:477–496
- Jeloka TK, Shrividya S, Wagholikar G. Catheter outflow obstruction due to an Aspergilloma. Perit Dial Int. 2011;31(2):211–212
- Kozel TR. Activation of the complement system by the pathogenic fungi. Clin Microbiol Rev. 1996;9(1):34–46
- Zuber J, Fakhouri F, Roumenina TL, Loirat C, Fremeaux-Bacchi V. Use of Eculizumab for atypical hemolytic uremic syndrome and C3 glomerulopathies. Nat Rev Nephrol. 2012;8:643–657